Benzylpiperazine: the New Zealand legal perspective.

Abstract

In 2005 the New Zealand Government created a new schedule of ‘Restricted Substances’ under the Misuse of Drugs Act (1975). Benzylpiperazine was the first drug to be classified as what became known informally as ‘Class D’. The rationale behind that decision and the subsequent reclassification of benzylpiperazine to Class C, in 2008, is discussed

    Similar works

    Full text

    thumbnail-image

    Sheffield Hallam University Research Archive

    redirect
    Last time updated on 18/02/2012

    Having an issue?

    Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.